Edward J Stepanski discusses the underlying tension between payers and providers with respect to the aims of clinical pathways and the recent policy statement released by the American Society of Clinical Oncology. 
The essential role of patient navigation and care coordination services in helping patients to adhere to their treatment plans.
The authors discuss tactics for ensuring appropriate compliance with clinical pathways among health care providers in large-scale health networks.
This article provides a comprehensive review of psoriasis and of the practical obstacles encountered in optimizing care of patients with moderate-to-severe disease.
Before the relative value of a drug can be determined, one must first consider how value is defined by the patient. Dr. Benson and Ms. McClure respond to a viewpoint by Roger Longman, MA. 
Roger Longman, MA, offers a perspective on how we can overcome comparative effectiveness research and bring a greater understanding on which drugs work best. 
Clinical pathways are intended to be used by a multidisciplinary health care team in order to achieve the Triple Aim of healthcare reform.